Vanillin Protects the Blood–milk Barrier and Inhibits the Inflammatory Response in LPS-induced Mastitis in Mice
Wenjin Guo,Bingrun Liu,Guiqiu Hu,Xingchi Kan,Yanwei Li,Qian Gong,Dianwen Xu,He Ma,Yu Cao,Bingxu Huang,Shoupeng Fu,Juxiong Liu
DOI: https://doi.org/10.1016/j.taap.2018.12.022
IF: 4.46
2019-01-01
Toxicology and Applied Pharmacology
Abstract:Vanillin is used in a variety of food, chemical, and pharmaceutical applications, and exhibits anti-inflammatory properties. However, there are no reports about the effects of vanillin on lipopolysaccharide (LPS)-induced mastitis. In this study, we explored the effects of vanillin on the subsequent inflammatory response and blood milk barrier in LPS-induced mastitis. Results showed that vanillin suppressed the inflammatory response by a) inhibiting myeloperoxidase activity; b) decreasing the production of pro-inflammatory mediators which include tumor necrosis factor alpha (Tnf-alpha; from 128.5 +/- 14.59 to 67.51 +/- 10.88,pg/mL, P < 0.01), interleukin-6 (Il-6; from 531.5 +/- 196.4 to 109.3 +/- 24.14, pg/mL, P < 0.05), interleukin-1 beta (Il-1 beta; from 2569 +/- 1648 to 731.8 +/- 171.7, pg/mL, P < 0.05), inducible nitric oxide synthase (Inos), and cyclooxygenase-2 (Cox-2); and c) repairing the blood-milk barrier by increasing the protein levels of the tight junction proteins, including zona occludens 1 (Zo-1), claudin-3, and occludin. In vitro experiment, Vanillin can inhibit LPS-induced inflammation and enhance the protein levels of tight junction proteins. Further studies have shown that vanillin inhibits inflammation by inhibiting mitogen-activated protein kinases (MAPKs) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappa B) signaling pathways. Our findings showed that vanillin protects mammary gland from LPS-induced mastitis by enhancing the blood milk barrier and inhibiting the inflammatory response.